Surfactant Protein D in Chornic Obstructive Pulmonary Disease (COPD)

Publisher： Bentham Science Publishers

E-ISSN： 2212-3334|8|1|42-47

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.8, Iss.1, 2014-01, pp. : 42-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of Phosphoinositol 3 Kinase and NF&kgr;B for the Treatment of Chronic Obstructive Pulmonary Disease

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 5, Iss. 3, 2011-09 ,pp. : 178-183

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Mucomodulator Therapy for Treatment of Excess Airway Mucus in Patients with Asthma, Chronic Obstructive Pulmonary Disease and Cystic Fibrosis

By  

Recent Patents on Materials Science, Vol. 5, Iss. 3, 2012-07 ,pp. : 222-240

Bentham Science Publishers

Access to resources Recommend Favorite

Surfactant Therapy of Pulmonary Conditions Excluding those with Primary Surfactant Deficiency and Bronchoscopy as Delivery Method: An Overview of Russian Patents and Publications

By  

Recent Patents on Drug Delivery & Formulation, Vol. 7, Iss. 2, 2013-08 ,pp. : 134-137

Bentham Science Publishers

Access to resources Recommend Favorite

Potential of Lung Surfactant Proteins, SP-A and SP-D, and Mannan Binding Lectin for Therapy and Genetic Predisposition to Allergic and Invasive Aspergillosis

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 1, Iss. 3, 2007-11 ,pp. : 183-187

Bentham Science Publishers

Access to resources Recommend Favorite

Vaccines for Patients with COPD

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 9, Iss. 1, 2015-04 ,pp. : 23-30

Bentham Science Publishers

Access to resources Recommend Favorite